Entrada Therapeutics (TRDA)
(Delayed Data from NSDQ)
$14.72 USD
-0.31 (-2.06%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $14.70 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.67 |
EPS Last Quarter | 1.55 |
Last EPS Surprise | 138.46% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.68 |
Next Year | -3.75 |
EPS (TTM) | 2.96 |
P/E (F1) | 22.21 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.25M | 14.25M | 183.55M | 46.47M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 20.00M | 16.00M | 189.81M | 56.42M |
Low Estimate | 12.50M | 12.50M | 178.81M | 35.00M |
Year ago Sales | 43.74M | 41.85M | 129.01M | 183.55M |
Year over Year Growth Est. | -62.85% | -65.95% | 42.27% | -74.68% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.67 | -0.77 | 0.68 | -3.75 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.47 | -0.67 | 0.88 | -3.74 |
High Estimate | -0.47 | -0.67 | 0.88 | -3.70 |
Low Estimate | -0.88 | -0.92 | 0.43 | -3.82 |
Year ago EPS | 1.02 | -0.29 | -0.20 | 0.68 |
Year over Year Growth Est. | -165.69% | -165.52% | 440.00% | -651.47% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 3 | 1 |
Up Last 60 Days | 1 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 0 | 2 |
Down Last 60 Days | 2 | 2 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.67 | -0.77 | 0.68 | -3.75 |
7 Days Ago | -0.67 | -0.77 | 0.68 | -3.75 |
30 Days Ago | -0.64 | -0.77 | -0.13 | -3.21 |
60 Days Ago | -0.64 | -0.77 | -0.13 | -3.21 |
90 Days Ago | -0.65 | -0.82 | -0.14 | -3.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.77 | 0.68 | -3.75 |
Zacks Consensus Estimate | -0.67 | -0.77 | 0.68 | -3.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.55 | 0.68 | -0.29 | 1.02 | NA |
Estimate | 0.65 | -0.38 | -0.07 | -0.55 | NA |
Difference | 0.90 | 1.06 | -0.22 | 1.57 | 0.83 |
Surprise | 138.46% | 278.95% | -314.29% | 285.45% | 97.14% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more